WATS 3D
Detection of dysplasia in Barrett's Esophagus
CommercialActive
Key Facts
Indication
Detection of dysplasia in Barrett's Esophagus
Phase
Commercial
Status
Active
Company
About CDx Diagnostics
CDx Diagnostics is a commercial-stage diagnostics company specializing in AI-powered early cancer detection. Its flagship product, WATS 3D, is an adjunctive test for esophageal precancer that combines enhanced tissue sampling with a neural network for analysis and 3D imaging, recently receiving FDA Breakthrough Device Designation. The company targets the significant market for Barrett's esophagus surveillance, aiming to improve patient outcomes and reduce healthcare costs by catching dysplasia earlier than standard biopsies. It operates as a private company, generating revenue through its diagnostic testing services.
View full company profile